Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Human Cytomegalovirus Cell Tropism and Host Cell Receptors.

Gerna G, Kabanova A, Lilleri D.

Vaccines (Basel). 2019 Jul 22;7(3). pii: E70. doi: 10.3390/vaccines7030070. Review.

2.

An overview of letermovir: a cytomegalovirus prophylactic option.

Gerna G, Lilleri D, Baldanti F.

Expert Opin Pharmacother. 2019 Jul 8:1-10. doi: 10.1080/14656566.2019.1637418. [Epub ahead of print]

PMID:
31282759
3.

Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss.

Suárez NM, Wilkie GS, Hage E, Camiolo S, Holton M, Hughes J, Maabar M, Vattipally SB, Dhingra A, Gompels UA, Wilkinson GWG, Baldanti F, Furione M, Lilleri D, Arossa A, Ganzenmueller T, Gerna G, Hubáček P, Schulz TF, Wolf D, Zavattoni M, Davison AJ.

J Infect Dis. 2019 Jul 31;220(5):781-791. doi: 10.1093/infdis/jiz208.

4.

Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.

Gerna G, Lilleri D.

New Microbiol. 2019 Jan;42(1):1-20. Epub 2019 Jan 21. Review.

5.
6.
7.

False human cytomegalovirus IgG-positivity at prenatal screening.

Furione M, Sarasini A, Arossa A, Fornara C, Lilleri D, Perez L, Parea M, Zavattoni M, Spinillo A, Marone P, Baldanti F.

J Clin Virol. 2018 Jul;104:34-38. doi: 10.1016/j.jcv.2018.04.009. Epub 2018 Apr 21.

PMID:
29705613
8.

Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission.

Mele F, Fornara C, Jarrossay D, Furione M, Arossa A, Spinillo A, Lanzavecchia A, Gerna G, Sallusto F, Lilleri D.

PLoS One. 2017 Nov 7;12(11):e0187731. doi: 10.1371/journal.pone.0187731. eCollection 2017.

9.

The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development.

Gerna G, Revello MG, Baldanti F, Percivalle E, Lilleri D.

J Gen Virol. 2017 Sep;98(9):2215-2234. doi: 10.1099/jgv.0.000882. Epub 2017 Aug 15. Review.

PMID:
28809151
10.

Incidence of human cytomegalovirus infection and T-cell response in patients with psoriasis before and during antitumour necrosis factor-α therapy.

Fornara L, Fornara C, Cananzi R, Lilleri D, Furione M, Brazzelli V.

Br J Dermatol. 2017 Dec;177(6):e323-e324. doi: 10.1111/bjd.15650. Epub 2017 Nov 29. No abstract available.

PMID:
28494092
11.

Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.

Lilleri D, Gerna G.

Rev Med Virol. 2017 Mar;27(2). doi: 10.1002/rmv.1921. Epub 2016 Dec 23. Review.

PMID:
28008685
12.

Corrigendum to Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.

Bruno F, Fornara C, Zelini P, Furione M, Carrara E, Scaramuzzi L, Cane I, Mele F, Sallusto F, Lilleri D, Gerna G.

J Gen Virol. 2016 Oct;97(10):2798. doi: 10.1099/jgv.0.000615. No abstract available.

PMID:
27902353
13.

Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.

Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, Lilleri D.

New Microbiol. 2016 Oct;39(4):247-258. Epub 2016 Sep 13.

14.

Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.

Kabanova A, Marcandalli J, Zhou T, Bianchi S, Baxa U, Tsybovsky Y, Lilleri D, Silacci-Fregni C, Foglierini M, Fernandez-Rodriguez BM, Druz A, Zhang B, Geiger R, Pagani M, Sallusto F, Kwong PD, Corti D, Lanzavecchia A, Perez L.

Nat Microbiol. 2016 Jun 6;1(8):16082. doi: 10.1038/nmicrobiol.2016.82.

15.

Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.

Lilleri D, Gerna G.

Immunotherapy. 2016 Sep;8(9):1135-49. doi: 10.2217/imt-2015-0028. Review.

PMID:
27485084
16.

Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.

Lilleri D, Gerna G, Furione M, Zavattoni M, Spinillo A.

J Clin Virol. 2016 Aug;81:16-24. doi: 10.1016/j.jcv.2016.05.007. Epub 2016 May 17.

PMID:
27289427
17.
18.

Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.

Bruno F, Fornara C, Zelini P, Furione M, Carrara E, Scaramuzzi L, Cane I, Mele F, Sallusto F, Lilleri D, Gerna G.

J Gen Virol. 2016 Aug;97(8):1928-41. doi: 10.1099/jgv.0.000488. Epub 2016 Apr 25. Erratum in: J Gen Virol. 2016 Oct;97(10):2798.

PMID:
27113912
19.

Analytic Vaccinology: Antibody-Driven Design of a Human Cytomegalovirus Subunit Vaccine.

Kabanova A, Lilleri D.

Methods Mol Biol. 2016;1403:167-86. doi: 10.1007/978-1-4939-3387-7_8.

PMID:
27076130
21.

Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.

Gabanti E, Lilleri D, Ripamonti F, Bruno F, Zelini P, Furione M, Colombo AA, Alessandrino EP, Gerna G.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2192-2202. doi: 10.1016/j.bbmt.2015.08.002. Epub 2015 Aug 8.

22.

Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.

Fornara C, Furione M, Lilleri D, Cane I, Revello MG, Zavattoni M, Gerna G.

J Clin Virol. 2015 Mar;64:45-51. doi: 10.1016/j.jcv.2015.01.004. Epub 2015 Jan 6.

PMID:
25728078
23.

Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Gibson L, Barysauskas CM, McManus M, Dooley S, Lilleri D, Fisher D, Srivastava T, Diamond DJ, Luzuriaga K.

J Clin Immunol. 2015 Apr;35(3):289-301. doi: 10.1007/s10875-015-0139-3. Epub 2015 Feb 25.

24.

Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies.

Kabanova A, Perez L, Lilleri D, Marcandalli J, Agatic G, Becattini S, Preite S, Fuschillo D, Percivalle E, Sallusto F, Gerna G, Corti D, Lanzavecchia A.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17965-70. doi: 10.1073/pnas.1415310111. Epub 2014 Dec 1.

25.

Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.

Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, Furione M, Revello MG.

J Gen Virol. 2015 Feb;96(Pt 2):360-9. doi: 10.1099/vir.0.070441-0. Epub 2014 Oct 14.

PMID:
25316796
26.

Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.

Gabanti E, Bruno F, Fornara C, Bernuzzi S, Lilleri D, Gerna G.

J Clin Immunol. 2014 Nov;34(8):999-1008. doi: 10.1007/s10875-014-0093-5. Epub 2014 Sep 18.

PMID:
25231588
27.

Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.

Gabanti E, Bruno F, Lilleri D, Fornara C, Zelini P, Cane I, Migotto C, Sarchi E, Furione M, Gerna G.

PLoS One. 2014 Aug 28;9(8):e106044. doi: 10.1371/journal.pone.0106044. eCollection 2014.

28.

Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women.

Revello MG, Fornara C, Arossa A, Zelini P, Lilleri D.

Early Hum Dev. 2014 Mar;90 Suppl 1:S32-4. doi: 10.1016/S0378-3782(14)70011-8. Review.

PMID:
24709453
29.

New advances in CMV and immunosenescence.

Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, Cičin-Šain L, Dechanet-Merville J, Derhovanessian E, Ferrando-Martinez S, Franceschi C, Frasca D, Fulöp T, Furman D, Gkrania-Klotsas E, Goodrum F, Grubeck-Loebenstein B, Hurme M, Kern F, Lilleri D, López-Botet M, Maier AB, Marandu T, Marchant A, Matheï C, Moss P, Muntasell A, Remmerswaal EB, Riddell NE, Rothe K, Sauce D, Shin EC, Simanek AM, Smithey MJ, Söderberg-Nauclér C, Solana R, Thomas PG, van Lier R, Pawelec G, Nikolich-Zugich J.

Exp Gerontol. 2014 Jul;55:54-62. doi: 10.1016/j.exger.2014.03.020. Epub 2014 Apr 3.

30.

Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.

Lilleri D, Gerna G, Bruno F, Draghi P, Gabanti E, Fornara C, Meloni F.

New Microbiol. 2013 Jul;36(3):267-77. Epub 2013 Jun 30.

31.

Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.

Furione M, Rognoni V, Sarasini A, Zavattoni M, Lilleri D, Gerna G, Revello MG.

J Med Virol. 2013 Nov;85(11):1960-7. doi: 10.1002/jmv.23691. Epub 2013 Jul 25.

PMID:
23893782
32.

Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

Lilleri D, Kabanova A, Revello MG, Percivalle E, Sarasini A, Genini E, Sallusto F, Lanzavecchia A, Corti D, Gerna G.

PLoS One. 2013;8(3):e59863. doi: 10.1371/journal.pone.0059863. Epub 2013 Mar 29.

33.

Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.

Lilleri D, Gerna G, Zelini P, Chiesa A, Rognoni V, Mastronuzzi A, Giorgiani G, Zecca M, Locatelli F.

PLoS One. 2012;7(7):e41648. doi: 10.1371/journal.pone.0041648. Epub 2012 Jul 25.

34.

Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.

Gerna G, Lilleri D, Furione M, Castiglioni B, Meloni F, Rampino T, Agozzino M, Arbustini E.

New Microbiol. 2012 Jul;35(3):279-87. Epub 2012 Jun 30.

35.

Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Lilleri D, Kabanova A, Lanzavecchia A, Gerna G.

J Clin Immunol. 2012 Dec;32(6):1324-31. doi: 10.1007/s10875-012-9739-3. Epub 2012 Jul 27.

PMID:
22836657
36.

Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008-2009.

Piralla A, Lilleri D, Sarasini A, Marchi A, Zecca M, Stronati M, Baldanti F, Gerna G.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):162-7. doi: 10.1016/j.diagmicrobio.2012.02.019. Epub 2012 Apr 10.

PMID:
22494556
37.

Infections and organ transplantation: new challenges for prevention and treatment--a colloquium.

Grossi PA, Costa AN, Fehily D, Blumberg EA, Kuehnert MJ, Fishman JA, Ison MG, Lattes R, Kotton CN, Lilleri D, Kabanova A, Lanzavecchia A, Gerna G, Razonable RR, Comoli P, Zecca M, Basso S, Ginevri F, Grossi A, Schena FP, Rimola A, Burra P, De Martin E, Rodriguez-Castro KI, Fagiuoli S, Pasulo L, Bruno R, Andreone P, Loggi E, Arena F, Rossolini GM, Sganga G, Cozza V.

Transplantation. 2012 Mar 15;93(5 Suppl):S4-S39. doi: 10.1097/TP.0b013e3182481347. No abstract available.

PMID:
22374265
38.

Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy.

Fornara C, Lilleri D, Revello MG, Furione M, Zavattoni M, Lenta E, Gerna G.

J Clin Immunol. 2011 Dec;31(6):1054-64. doi: 10.1007/s10875-011-9577-8. Epub 2011 Aug 17.

PMID:
21847524
39.

Heart rate and cardiac allograft vasculopathy in heart transplant recipients.

Olmetti F, Pinna GD, Maestri R, D'Armini A, Pellegrini C, Viganò M, Lilleri D, Gerna G, Febo O, La Rovere MT.

J Heart Lung Transplant. 2011 Dec;30(12):1368-73. doi: 10.1016/j.healun.2011.07.009. Epub 2011 Aug 15.

PMID:
21840733
40.

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.

Gerna G, Lilleri D, Chiesa A, Zelini P, Furione M, Comolli G, Pellegrini C, Sarchi E, Migotto C, Bonora MR, Meloni F, Arbustini E.

Am J Transplant. 2011 Nov;11(11):2463-71. doi: 10.1111/j.1600-6143.2011.03636.x. Epub 2011 Aug 9.

41.
42.

Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience.

Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Cena C, Arossa A, Montanari L, Rognoni V, Spinillo A, Gerna G.

J Clin Virol. 2011 Apr;50(4):303-7. doi: 10.1016/j.jcv.2010.12.012. Epub 2011 Feb 1.

PMID:
21277825
43.

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood.

Fabbri E, Revello MG, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Rustico M, Nicolini U, Ferrazzi E, Gerna G.

BJOG. 2011 Mar;118(4):448-56. doi: 10.1111/j.1471-0528.2010.02822.x. Epub 2010 Dec 24.

44.

Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host.

Zelini P, Lilleri D, Comolli G, Rognoni V, Chiesa A, Fornara C, Locatelli F, Meloni F, Gerna G.

Clin Immunol. 2010 Aug;136(2):269-81. doi: 10.1016/j.clim.2010.04.008. Epub 2010 May 20.

PMID:
20493777
45.

Multicenter quality control study for human cytomegalovirus DNAemia quantification.

Lilleri D, Lazzarotto T, Ghisetti V, Ravanini P, Capobianchi MR, Baldanti F, Gerna G; SIV-AMCLI Transplant Surveillance Group.

New Microbiol. 2009 Jul;32(3):245-53.

46.

Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients.

Gerna G, Lilleri D, Rognoni V, Agozzino M, Meloni F, Oggionni T, Pellegrini C, Arbustini E, D'Armini AM.

Am J Transplant. 2009 May;9(5):1142-50. doi: 10.1111/j.1600-6143.2009.02616.x.

47.

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.

Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G.

Clin Immunol. 2009 Jun;131(3):395-403. doi: 10.1016/j.clim.2009.02.002. Epub 2009 Mar 5.

PMID:
19268633
48.

Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.

Lilleri D, Gerna G, Fornara C, Chiesa A, Comolli G, Zecca M, Locatelli F.

J Infect Dis. 2009 Mar 15;199(6):829-36. doi: 10.1086/597123.

PMID:
19239337
50.

Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation.

Gerna G, Lilleri D, Callegaro A, Goglio A, Cortese S, Stroppa P, Torre G.

Transplantation. 2008 Jul 15;86(1):163-6. doi: 10.1097/TP.0b013e31817889e4.

PMID:
18622294

Supplemental Content

Loading ...
Support Center